| Dr Joseph P Larochelle, OD | |
|
8 N State St, Concord, NH 03301-4038 | |
| (603) 225-2512 | |
| (603) 225-3249 |
| Full Name | Dr Joseph P Larochelle |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 8 N State St, Concord, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801933791 | NPI | - | NPPES |
| 300008880 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 0362 (New Hampshire) | Primary |
| Provider Name | Concord Family Vision Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1396101358 PECOS PAC ID: 0042518078 Enrollment ID: O20160407001414 |
News Archive
A cellular component known as the Golgi apparatus may play a role in how lung cancer metastasizes, according to researchers at The University of Texas MD Anderson Cancer Center whose findings were reported in the Nov. 21 online issue of the Journal of Clinical Investigation.
Oncolytics Biotech Inc. announced today that it has completed Phase I patient enrollment in its Phase I/II clinical trial to investigate the use of REOLYSIN(R) for patients with recurrent malignant gliomas (REO 007). The principal investigator is Dr. James Markert, Division Director of Neurosurgery, and Professor, Neurosurgery and Physiology, the University of Alabama at Birmingham.
In the latest installment of the PLOS "Speaking of Medicine" blog's Q&A series, Pamela Collins, director of the Office for Research on Disparities and Global Mental Health at the National Institute of Mental Health and "the corresponding author of a series of Policy Forum articles in PLOS Medicine that provides a global perspective on integrating mental health," answers questions "about some of the topics discussed in the new series, which will be published in PLOS Medicine weekly for the next five weeks, starting with the publication [on Tuesday] of a Policy Forum article discussing integration in research, policy, and practice."
Acura Pharmaceuticals, Inc. today reported a second quarter 2010 net loss of $3.2 million or $0.07 per share compared to net loss of $6.5 million, or $0.14 per share for the second quarter of 2009. For the six months ended June 30, 2010, the Company reported a net loss of $7.2 million, or $0.15 per share compared to net loss of $7.8 million, or $0.17 per share for the same period in 2009. At July 29, 2010 we had cash and cash equivalents of approximately $26.5 million with no term indebtedness.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph P Larochelle, OD 8 N State St, Concord, NH 03301-4038 Ph: (603) 225-2512 | Dr Joseph P Larochelle, OD 8 N State St, Concord, NH 03301-4038 Ph: (603) 225-2512 |
News Archive
A cellular component known as the Golgi apparatus may play a role in how lung cancer metastasizes, according to researchers at The University of Texas MD Anderson Cancer Center whose findings were reported in the Nov. 21 online issue of the Journal of Clinical Investigation.
Oncolytics Biotech Inc. announced today that it has completed Phase I patient enrollment in its Phase I/II clinical trial to investigate the use of REOLYSIN(R) for patients with recurrent malignant gliomas (REO 007). The principal investigator is Dr. James Markert, Division Director of Neurosurgery, and Professor, Neurosurgery and Physiology, the University of Alabama at Birmingham.
In the latest installment of the PLOS "Speaking of Medicine" blog's Q&A series, Pamela Collins, director of the Office for Research on Disparities and Global Mental Health at the National Institute of Mental Health and "the corresponding author of a series of Policy Forum articles in PLOS Medicine that provides a global perspective on integrating mental health," answers questions "about some of the topics discussed in the new series, which will be published in PLOS Medicine weekly for the next five weeks, starting with the publication [on Tuesday] of a Policy Forum article discussing integration in research, policy, and practice."
Acura Pharmaceuticals, Inc. today reported a second quarter 2010 net loss of $3.2 million or $0.07 per share compared to net loss of $6.5 million, or $0.14 per share for the second quarter of 2009. For the six months ended June 30, 2010, the Company reported a net loss of $7.2 million, or $0.15 per share compared to net loss of $7.8 million, or $0.17 per share for the same period in 2009. At July 29, 2010 we had cash and cash equivalents of approximately $26.5 million with no term indebtedness.
› Verified 8 days ago
Mr. Charles Edward Daniels Iii, OD Optometrist Medicare: Medicare Enrolled Practice Location: 8 N State St, Concord, NH 03301 Phone: 603-225-2512 Fax: 603-225-3249 | |
Rachel Roman, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 304 Sheep Davis Rd, Concord, NH 03301 Phone: 603-226-1255 | |
Dr. Karl Cameron Engelhart, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 153 Manchester St, Concord, NH 03301 Phone: 603-226-0855 Fax: 603-226-0981 | |
Dr. Anthony N Sacco, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 21 Green St, Concord, NH 03301 Phone: 603-224-0971 | |
Douglas P Benoit, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2 Pillsbury St Ste 100, Concord, NH 03301 Phone: 603-228-1104 Fax: 603-228-7061 | |
Ziwei Wu, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2 Pillsbury St Ste 100, Concord, NH 03301 Phone: 603-224-2020 | |
Dr. Abbie Louise Martin, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8 N State St, Concord, NH 03301 Phone: 603-225-2512 |